Evaluating the Clomiphene Citrate versus Letrozole among infertile patients: Case Report

Maram Salah M. Khalil; Elmahaishi MS; Hungarian Board

doi:10.58372/2835-6276.1409

Authors

Maram Salah M. Khalil
Elmahaishi MS
Hungarian Board

DOI:

https://doi.org/10.58372/2835-6276.1409

Keywords:

Clomiphene citrate, Letrozole, Ovulation induction, Female infertility, Polycystic ovary syndrome (PCOS)

Abstract

Background: Infertility, defined as the inability to conceive after 12 months of unprotected intercourse in women under 35 years or after 6 months in women aged 35 years or older, affects 8–12% of women worldwide. Clomiphene citrate, a selective estrogen receptor modulator, and letrozole, an aromatase inhibitor, are widely used agents for ovarian stimulation.

Objective: To compare the effectiveness of clomiphene citrate and letrozole in infertile women at Lamis Infertility Center, Misurata, Libya.

Methods: A randomized controlled trial was conducted at Lamis Infertility Center, Misurata, Libya, between January and December 2025. Two hundred infertile women were randomly assigned to receive either clomiphene citrate (n=100) or letrozole (n=100). Clinical data were collected and analyzed to assess treatment outcomes with IBM SPSS v24.

Results: The mean age of participants was 34.2 ± 7.8 years. Primary and secondary infertility were equally represented (50% each), with unexplained infertility accounting for 81% of cases. Ovarian hyperstimulation occurred in 8% overall (10% in the letrozole group vs. 6% in the clomiphene group). Pregnancy was achieved in 86% of cases (172/200), with a significantly higher rate in the letrozole group (94/100, 94%) compared to the clomiphene citrate group (78/100, 78%) (p = 0.021).

Conclusion: Letrozole demonstrated superior pregnancy outcomes compared to clomiphene citrate, although with a slightly increased risk of ovarian hyperstimulation in women with polycystic ovarian syndrome. Age, infertility type, and unexplained infertility influenced treatment response. Letrozole may be considered a preferred option for enhancing pregnancy rates in infertile women.

References

Practice Committee of American Society for Reproductive M Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63. doi: 10.1016/j.fertnstert.2012.09.023. [DOI] [PubMed] [Google Scholar]

Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10. doi: 10.1016/j.clinbiochem.2018.03.012. [DOI] [PubMed] [Google Scholar]

Tuntiseranee P, Olsen J, Chongsuvivatwong V, Limbutara S. Fecundity in Thai and European regions: results based on waiting time to pregnancy. Hum Reprod. 1998;13(2):471–7. doi: 10.1093/humrep/13.2.471. [DOI] [PubMed] [Google Scholar]

Unuane D, Tournaye H, Velkeniers B, Poppe K. Endocrine Disorders & female infertility. Best Pract Res Clin Endocrinol Metab. 2011;25(6):861–73. doi: 10.1016/j.beem.2011.08.001. [DOI] [PubMed] [Google Scholar]

Weiss RV, Clapauch R. Female infertility of endocrine origin. Arq Bras Endocrinol Metabol. 2014;58(2):144–52. doi: 10.1590/0004-2730000003021. [DOI] [PubMed] [Google Scholar]

Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015;28(2):116–20. doi: 10.2337/diaspect.28.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]

Collee J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility:Overview and insights of the putative treatments. Gynecological Endocrinol. 2021;37(10):869–874. doi: 10.1080/09513590.2021.1958310. doi:10.1080/09513590.2021.1958310. [DOI] [PubMed] [Google Scholar]

Seyedoshohadaei F, Tangestani L, Zandvakili F, Rashadmanesh N. Comparison of the Effect of Clomiphene- Estradiol Valerate vs Letrozole on Endometrial Thickness, Abortion and Pregnancy Rate in Infertile Women with Polycystic Ovarian Syndrome. J Clin Diag Res. 2016;10(8):QC10. doi: 10.7860/JCDR/2016/20954.8324. doi:10.7860/JCDR/2016/20954.8324. [DOI] [PMC free article] [PubMed] [Google Scholar]

Amer SA, Smith J, Mahran A, Fox P, Fakis A. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod. 2017;32(8):1631–1638. doi: 10.1093/humrep/dex227. doi:10.1093/humrep/dex227. [DOI] [PMC free article] [PubMed] [Google Scholar]

Franik S, Eltrop SM, Kremer JA M, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3. doi:10.1002/14651858.CD010287.PUB3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome:approach to clinical practice. Clinics (Sao Paulo) 2015;70(11):765–9. doi: 10.6061/clinics/2015(11)09. doi:10.6061/clinics/2015(11)09. [DOI] [PMC free article] [PubMed] [Google Scholar]

Costello MF, Misso ML, Balen A, Boyle J, Devoto L, Garad RM, et al. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome:assessment and treatment of infertility. Hum Reprod Open. 2019;2019(1):hoy021. doi: 10.1093/hropen/hoy021. doi:10.1093/hropen/hoy021. [DOI] [PMC free article] [PubMed] [Google Scholar]

Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013 Jan;99(1):63. [PubMed]

Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility. Optimizing natural fertility. Fertil Steril. 2008 Nov;90(5 Suppl):S1-6. [PubMed]

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014 Mar;101(3):633-4. [PubMed]

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e1001356. [PMC free article] [PubMed]

Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015 Apr 26;13:37. [PMC free article] [PubMed]

Ombelet W. Global access to infertility care in developing countries: a case of human rights, equity and social justice. Facts Views Vis Obgyn. 2011;3(4):257-66. [PMC free article] [PubMed]

Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015 Jul-Aug;21(4):411-26. [PubMed]

Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol. 2007 Apr;21(2):293-308. [PubMed]

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 Jan;19(1):41-7. [PubMed]

Gordon CM. Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med. 2010 Jul 22;363(4):365-71. [PubMed]

Kodaman PH, Arici A. Intra-uterine adhesions and fertility outcome: how to optimize success? Curr Opin Obstet Gynecol. 2007 Jun;19(3):207-14. [PubMed]

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017 Sep;108(3):416-425. [PubMed]

Bulun SE. Endometriosis. N Engl J Med. 2009 Jan 15;360(3):268-79. [PubMed]

Elizur SE, Mostafa J, Berkowitz E, Orvieto R. Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes. Arch Gynecol Obstet. 2025 Oct;312(4):1037-1048. [PMC free article] [PubMed]

Gelbaya TA, Potdar N, Jeve YB, Nardo LG. Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv. 2014 Feb;69(2):109-15. [PubMed]

Homan GF, Davies M, Norman R. The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Hum Reprod Update. 2007 May-Jun;13(3):209-23. [PubMed]

Franssen MT, Korevaar JC, van der Veen F, Leschot NJ, Bossuyt PM, Goddijn M. Reproductive outcome after chromosome analysis in couples with two or more miscarriages: index [corrected]-control study. BMJ. 2006 Apr 01;332(7544):759-63. [PMC free article] [PubMed]

Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, Buck Louis GM. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013 Apr;99(5):1324-1331.e1. [PMC free article] [PubMed]

Carson SA, Kallen AN. Diagnosis and Management of Infertility: A Review. JAMA. 2021 Jul 06;326(1):65-76. [PMC free article] [PubMed]

Mathews TJ, Hamilton BE. Mean Age of Mothers is on the Rise: United States, 2000-2014. NCHS Data Brief. 2016 Jan;(232):1-8. [PubMed]

Abebe MS, Afework M, Abaynew Y. Primary and secondary infertility in Africa: systematic review with meta-analysis. Fertil Res Pract. 2020 Dec 02;6(1):20. [PMC free article] [PubMed]

Seifer DB, Zackula R, Grainger DA., Society for Assisted Reproductive Technology Writing Group Report. Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006. Fertil Steril. 2010 Feb;93(2):626-35. [PubMed]

Quinn M, Fujimoto V. Racial and ethnic disparities in assisted reproductive technology access and outcomes. Fertil Steril. 2016 May;105(5):1119-1123. [PubMed]

Gilbert K, Nangia AK, Dupree JM, Smith JF, Mehta A. Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology? Urol Oncol. 2018 Mar;36(3):92.e1-92.e9. [PubMed]

Mahalingaiah S, Hart JE, Laden F, Farland LV, Hewlett MM, Chavarro J, Aschengrau A, Missmer SA. Adult air pollution exposure and risk of infertility in the Nurses' Health Study II. Hum Reprod. 2016 Mar;31(3):638-47. [PMC free article] [PubMed]

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ., International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018 Aug;110(3):364-379. [PMC free article] [PubMed]

Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017 Aug;217(2):129-140. [PubMed]

Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010 Aug;94(3):1044-51. [PubMed]

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ., International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018 Sep 01;33(9):1602-1618. [PMC free article] [PubMed]